ScinoPharm Taiwan
1789.TW
0.58 USD
-0.01
-1.69%
s
Overview
Last close
0.58 usd
Market cap
457.51M usd
52 week high
0.89 usd
52 week low
0.51 usd
Target price
0.57 usd
Valuation
P/E
457.5
Forward P/E
40.3226
Price/Sales
4.717
Price/Book Value
1.3832
Enterprise Value
374.49M usd
EV/Revenue
3.8611
EV/EBITDA
21.9325
Key financials
Revenue TTM
96.99M usd
Gross Profit TTM
28.61M usd
EBITDA TTM
13.56M usd
Earnings per Share
0.01 usd
Dividend
0.01 usd
Total assets
388.77M usd
Net debt
-82.58M usd
About
ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
- Symbol1789.TW
- ExchangeTW
- IsinTW0001789006
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Chih-Hsien Lo
- HeadquarterTainan City
- Web sitehttps://www.scinopharm.com
